These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1525212)

  • 21. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
    Kim CJ; Parkinson DR; Marincola F
    J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG; Turcovski-Corrales SM; Taub DD
    J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates.
    Parker SE; Vahlsing HL; Serfilippi LM; Franklin CL; Doh SG; Gromkowski SH; Lew D; Manthorpe M; Norman J
    Hum Gene Ther; 1995 May; 6(5):575-90. PubMed ID: 7578395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
    Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
    Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/beta2-microglobulin gene in patients with cancer.
    Heo DS; Yoon SJ; Kim WS; Lee KH; Seol JG; Lee SG; Jung CW; Cho EK; Kim CW; Park MH; Sung MW; Kim KH; Bang YJ; Kim NK
    Hum Gene Ther; 1998 Sep; 9(14):2031-8. PubMed ID: 9759930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer immunogene therapy.
    Yoshizawa H; Kagamu H; Gejyo F
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):337-43. PubMed ID: 11798131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules.
    Liu Y; Wang H; Zhao J; Ma J; Wei L; Wu S; Xie T; Shen F; Trojan J; Habib N; Anthony DD; Wu M; Guo Y
    Cancer Gene Ther; 2000 Mar; 7(3):456-65. PubMed ID: 10766352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials.
    Horn NA; Meek JA; Budahazi G; Marquet M
    Hum Gene Ther; 1995 May; 6(5):565-73. PubMed ID: 7578394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic therapy targeting metastatic melanoma: allovectin-7.
    Chowdhery R; Gonzalez R
    Immunotherapy; 2011 Jan; 3(1):17-21. PubMed ID: 21174553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting HLA class I expression to increase tumor immunogenicity.
    del Campo AB; Carretero J; Aptsiauri N; Garrido F
    Tissue Antigens; 2012 Mar; 79(3):147-54. PubMed ID: 22309256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neck.
    Gleich LL; Gluckman JL; Nemunaitis J; Suen JY; Hanna E; Wolf GT; Coltrera MD; Villaret DB; Wagman L; Castro D; Gapany M; Carroll W; Gillespie D; Selk LM
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):775-9. PubMed ID: 11448348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
    Ogasawara M; Rosenberg SA
    Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I study of immunotherapy of malignant melanoma by direct gene transfer.
    Hersh EM; Akporiaye E; Harris D; Stopeck AT; Unger EC; Warneke JA; Kradjian SA
    Hum Gene Ther; 1994 Nov; 5(11):1371-84. PubMed ID: 7893808
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes.
    Lu J; Celis E
    Cancer Res; 2000 Sep; 60(18):5223-7. PubMed ID: 11016651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
    Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
    Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal development of bladder cancer and its relevance to the clinical potential of HLA antigen and TP53 based gene therapy.
    Nouri AM; Oliver RT; Nardgund VH
    Cancer Surv; 1998; 31():109-28. PubMed ID: 15281320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetic interventions for cancer.
    Nabel GJ; Nabel EG; Yang Z; Fox BA; Plautz GE; Gao X; Huang L; Shu S; Gordon D; Chang AE
    Cold Spring Harb Symp Quant Biol; 1994; 59():699-707. PubMed ID: 7587133
    [No Abstract]   [Full Text] [Related]  

  • 39. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B7.1/NHS76: a new costimulator fusion protein for the immunotherapy of solid tumors.
    Liu A; Hu P; Khawli LA; Epstein AL
    J Immunother; 2006; 29(4):425-35. PubMed ID: 16799338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.